Skip to content
GenoLensGenoLens

GHR

Chr 5p13.1-p12

growth hormone receptor

Aliases:
GHBP
MANE:
ENST00000230882.9

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • IUGR and IGF abnormalities

    BIALLELIC, autosomal or pseudoautosomal
  • Monogenic short stature

    BIALLELIC, autosomal or pseudoautosomal
  • Pituitary hormone deficiency

    BIALLELIC, autosomal or pseudoautosomal
  • Skeletal dysplasia

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Familial hypercholesterolaemia

  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal

+1 more panels — install the extension to see the full list inline on any page.

Disease associations (Open Targets)

  • Laron syndrome

    0.83
  • short stature due to partial GHR deficiency

    0.76
  • Turner syndrome

    0.60
  • acromegaly

    0.60
  • pituitary dwarfism

    0.60
  • Growth delay

    0.59
  • Prader-Willi syndrome

    0.57
  • chronic kidney disease

    0.55
  • gonadal dysgenesis

    0.53
  • growth hormone insensitivity syndrome

    0.52

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Growth hormone receptor

Receptor for pituitary gland growth hormone (GH1) involved in regulating postnatal body growth (PubMed:1549776, PubMed:2825030, PubMed:8943276). On ligand binding, couples to the JAK2/STAT5 pathway (PubMed:1549776, PubMed:15690087, PubMed:2825030, PubMed:8943276)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.